Researchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug ...

Researchers have uncovered surprising evidence that anxiety may be controlled not by neurons but by two dueling groups of ...

Rilparencel, a percutaneous minimally invasive injectable product prepared from patients’ own kidney cells, is being developed to treat those with stage 3b or 4 CKD and either type 1 or type 2 ...

Objective Response Rate Median Duration of Response Not Reached after 25 Months Follow UpLifileucel Launch in Previously Treated Advanced ...

Tumors were eradicated in 30% of mice receiving cGAS LNPs injected into the tumor, in combination with immune checkpoint blockade.

Booster Therapeutics is developing a novel therapeutic approach that aims to combat the accumulation of deviant proteins in cells, which are a major driver of Parkinson's and other complex diseases ...

Hyundai Motor Company held a ground breaking ceremony for its new hydrogen fuel cell production plant in Ulsan, South Korea.

PELSA, a high-throughput tool that rapidly detects protein–ligand interactions across hundreds of samples daily. By ...

Overview:  High-gain and high-uplink boosters provide stronger coverage in homes, vehicles, RVs, and boats, especially in ...

Granted FDA Breakthrough designation, CardiAMP Cell Therapy uses a patient’s own bone marrow cells delivered to the heart in a minimally invasive, catheter-based procedure intended to increase ...